Patent · US Expired

Method of using spiro piperidines to promote the release of growth hormone

US5652235A · kind A · utility

35Cited by
1References
9Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 30, 1996
Grant dateJul 29, 1997
Priority date
Expiry dateApr 30, 2016

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02P20/55
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

There are disclosed certain novel compounds identified as spiro piperidines and homologs which promote the release of growth hormone in humans and animals. This property can be utilized to promote the growth of food animals to render the production of edible meat products more efficient, and in humans, to treat physiological or medical conditions characterized by a deficiency in growth hormone secretion, such as short stature in growth hormone deficient children, and to treat medical conditions which are improved by the anabolic effects of growth hormone. Growth hormone releasing compositions containing such spiro compounds as the active ingredient thereof are also disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.